MabCure, Inc.
MBCIOTCEnergy● Active
$0.00
+$0.00(+100.00%)
Market Cap$14644
P/E Ratio—
52W High$0.0005
52W Low$0.00001
MabCure, Inc.（MBCI）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MBCI · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2011-12 | 2010-12 | 2009-12 | 2008-12 | 2007-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.50M | $0.00M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $0.50M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | 100.00% | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.39M | $0.35M | $0.40M | $0.00M | $0.00M |
| G&A Expenses | $0.00M | $0.67M | $0.73M | $0.53M | $0.00M |
| Total Operating Expenses | $1.21M | $1.02M | $1.36M | $0.54M | $0.11M |
| Operating Income | ($0.71M) | ($1.02M) | ($1.36M) | ($0.54M) | ($0.11M) |
| Operating Margin %(computed) | -141.95% | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.01M | $0.00M |
| Interest Expense | $0.19M | $0.21M | $0.02M | $0.00M | $0.00M |
| Income Before Tax | ($12.26M) | ($1.23M) | ($1.37M) | ($0.53M) | $0.00M |
| Income Tax Expense | $0.19M | $0.21M | $0.02M | $0.00M | $0.11M |
| Net Income | ($12.45M) | ($1.43M) | ($1.39M) | ($0.53M) | ($0.11M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.20 | $-0.02 | $-0.02 | $-0.01 | $-0.00 |
| Wtd Avg Shares | 63.71M | 62.05M | 60.36M | 43.10M | 49.68M |
| EBITDA | ($12.05M) | ($0.98M) | ($1.31M) | ($0.53M) | ($0.11M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解MabCure, Inc.
关于MabCure, Inc.（MBCI）损益表
MabCure, Inc.（MBCI）损益表数据来源于SEC Form 10-K及10-Q申报文件。2011财年，MBCI实现营收$0.00B，毛利润$0.00B（毛利率100.00%），净利润($0.01B)（净利率-2490.30%）。
常见问题
MBCI · 4 问MabCure, Inc.（MBCI）2011财年营收为$0.00B，同比up—%。
MBCI revenueMBCI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09